The uninsured charge will rise. Medicare Advantage enrollment will swell, with a lot less instability. Important pharmacy gain managers will start more transparent products and solutions. Here’s what field watchers expect in 2024. Read through the complete write-up ➔ Important hospital and provider … Read More


Novo CEO pressed by Senate to cut costs of weight problems, diabetes medications CEO Lars Fruergaard Jørgensen advised lawmakers the organization would consider new talks with insurers about the checklist price ranges of Wegovy and copyright if they pledge to help keep the medicines on their formula… Read More